Novocure Ltd
Change company Symbol lookup
Select an option...
NVCR Novocure Ltd
ESTC Elastic NV
STKH Steakholder Foods Ltd
NHEL Natural Health Farm Holdings Inc
ICPT Intercept Pharmaceuticals Inc
BMY Bristol-Myers Squibb Co
DTCFF Defence Therapeutics Inc
ADBE Adobe Inc
FATP Fat Projects Acquisition Corp
LGVC LAMF Global Ventures I Corp
Go

Health Care : Health Care Equipment & Supplies | Small Cap Blend
Based in Jersey
Company profile

NovoCure Limited is a global oncology company, which is principally engaged in the development, manufacturing and commercialization of Tumor Treating Fields (TTFields) devices, including Optune and Optune Lua, for the treatment of solid tumor cancers. TTFields are electric fields that exert physical forces to kill cancer cells via a variety of mechanisms. TTFields therapy has applicability across solid tumor types and lines of therapy. It is conducting phase three pivotal studies evaluating the use of TTFields in non-small cell lung cancer (NSCLC), ovarian cancer, brain metastases from NSCLC, and pancreatic cancer. The Company’s key priorities are to drive commercial adoption of Optune and Optune Lua, its commercial TTFields devices. The Company markets Optune in the United States, Germany, Japan and other countries. The Company markets Optune Lua in the United States and European Union. It also has a licence to market Optune in China, Hong Kong, Macau and Taiwan.

Price
Delayed
$17.24
Day's Change
-0.10 (-0.58%)
Bid
--
Ask
--
B/A Size
--
Day's High
17.82
Day's Low
17.20
Volume
(Light)

Today's volume of 605,591 shares is on pace to be much lighter than NVCR's 10-day average volume of 1,577,255 shares.

605,591
  • Prev Close
    17.34
  • Today's Open
    17.38
  • Day's Range
    17.20-17.82
  • Avg Vol (10-day)
    1.6M
  • Last (time)
    12:44p ET 09/26/23
  • Last (size)
    100
  • 52-Wk Range
    16.79 - 120.03
    LowHigh
  • (01/05/23 - 09/25/23)
    2.68%
  • 106.7%
  • Market Cap
    1.8B
  • Shares Outstanding
    106.6M
  • -1.65
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.7
  • 85.28
  • (% of float 08/31/23)
    8.75

Latest News

September 08, 2023
4:01 pm ET
BusinessWire
September 02, 2023
7:00 pm ET
Globe Newswire
August 30, 2023
5:06 am ET
Accesswire
August 29, 2023
6:31 pm ET
BusinessWire
5:00 am ET
Accesswire
August 28, 2023
1:53 pm ET
Newsfile
11:56 am ET
MarketWatch
8:36 am ET
MarketWatch
7:00 am ET
BusinessWire
August 25, 2023
7:00 am ET
BusinessWire
August 19, 2023
1:06 pm ET
Newsfile
August 18, 2023
2:16 pm ET
Accesswire
1:01 pm ET
Newsfile
12:46 pm ET
Newsfile
12:22 pm ET
Globe Newswire
11:30 am ET
Accesswire
11:05 am ET
Newsfile
11:00 am ET
Accesswire
6:30 am ET
Accesswire
5:01 am ET
Accesswire
August 17, 2023
9:00 pm ET
Accesswire
4:30 pm ET
Accesswire
4:03 pm ET
PR Newswire
2:31 pm ET
Accesswire
12:53 pm ET
BusinessWire
11:04 am ET
Newsfile
11:00 am ET
Accesswire
10:29 am ET
Newsfile
10:18 am ET
Accesswire
9:35 am ET
Newsfile
9:01 am ET
Accesswire
5:45 am ET
PR Newswire
5:00 am ET
Accesswire
August 16, 2023
9:00 pm ET
BusinessWire
8:57 pm ET
Accesswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.